NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

The Influence of Vibrotactile Stimulation on Self-selected Walking Speed in People With Parkinson's Disease

CompletedNA

Sponsor: Magnes AG

Conditions: Parkinson's Disease (PD)

Interventions: Vibrotactile feedback during walking

Countries: Switzerland

The study tests whether a smart shoe (NUSHU) that provides vibrotactile stimulation can improve walking speed in people with Parkinson's disease. Sixteen participants complete two short walking tests-with and without vibration-to compare gait speed, cadence, stride length, usability, and safety. It is a low-risk pilot study meant to generate first evidence for future research.

Eligibility overview

Sex: ALL

Age: 18 Years to —

Healthy volunteers: No

Study type: INTERVENTIONAL

Eligibility criteria

Inclusion criteria:

* A medically confirmed diagnosis of Parkinson's disease on the physiotherapy prescription.
* Stable medication for at least four weeks (no change in dopaminergic therapy).
* The ability to walk at least 200 metres without stopping.
* Minimum age: 18 years
* Sufficient knowledge of German to understand the study information and complete the questionnaires.
* Written informed consent form

Exclusion criteria:

* Atypical or secondary Parkinsonism
* Sensory disturbances in the feet (e.g. polyneuropathy).
* Other neurological, orthopaedic or internal medical conditions that significantly affect walking
* Cognitive impairments that interfere with understanding the study information or following instructions

Locations (1)

Zurich, Canton of Zurich, Switzerland